The shares of Daiichi Sankyo are traded on the Tokyo Stock Exchange (TSE), Osaka Stock Exchange (OSE) and Nagoya Stock Exchange (NSE). The shares are not traded on European stock exchanges at this time.
As a result, the Daiichi Sankyo Investor Relations Department in Tokyo is responsible for shareholder relations and support. All financial information and reports are provided by the company’s headquarters.
Nearly half of the shares are held by financial institutions. More than 70 per cent are held in Japan. As of 31 March 2011, the company had 115,142 shareholders. more...
The Daiichi Sankyo Group is one of the world's 20 leading global pharmaceutical companies. By 2015, the company wants to achieve recognition as a "Global Pharma Innovator". more...
In fiscal year 2010, Daiichi Sankyo increased its net sales from €7.56 billion to €8.55 billion. Net income rose to €619.8 million. These results were achieved by about 30,500 employees worldwide. more...